John M. Leonard, President and CEO at Intellia Therapeutics, Inc. (NTLA), sold 233,624 shares at $63.24 ($15.5M) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Open-market sale of $15.5M NTLA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.24 | 1,709 | $108K | 0.7% |
| 2 | $63.24 | 1,709 | $108K | 0.7% |
| 3 | $63.29 | 6,448 | $408K | 2.6% |
| 4 | $63.29 | 6,448 | $408K | 2.6% |
| 5 | $63.30 | 11,100 | $703K | 4.5% |
| 6 | $63.32 | 16,750 |
| $1.1M |
| 6.8% |
| 7 | $64.09 | 9,432 | $604K | 3.9% |
| 8 | $64.09 | 9,432 | $604K | 3.9% |
| 9 | $64.10 | 16,640 | $1.1M | 6.9% |
| 10 | $64.13 | 26,058 | $1.7M | 10.8% |
| 11 | $64.13 | 26,058 | $1.7M | 10.8% |
| 12 | $64.16 | 3,497 | $224K | 1.4% |
| 13 | $64.16 | 3,497 | $224K | 1.4% |
| 14 | $65.00 | 8,827 | $574K | 3.7% |
| 15 | $65.02 | 693 | $45K | 0.3% |
| 16 | $65.03 | 3,260 | $212K | 1.4% |
| 17 | $65.03 | 3,260 | $212K | 1.4% |
| 18 | $65.04 | 5,475 | $356K | 2.3% |
| 19 | $65.04 | 5,475 | $356K | 2.3% |
| 20 | $72.00 | 30,998 | $2.2M | 14.4% |
| 21 | $73.00 | 36,858 | $2.7M | 17.3% |
| Total | $66.52 avg | 233,624 | $15.5M | 100% |
| Filing → |
| NTLA | SELL | 2025-12-12 | $1.7M | — | Filing → |
| NTLA | SELL | 2025-01-07 | $653K | — | Filing → |
| NTLA | SELL | 2024-01-05 | $1.1M | — | Filing → |